Overall survival and long-term safety data from the NETTER-1 trial: 177-Lu-DOTATATE vs. high-dose octreotide in patients with progressive midgut NETs Meeting Abstract
| Authors: | Strosberg, J.; Caplin, M.; Kunz, P.; Ruszniewski, P.; Bodei, L.; Hendifar, A.; Mittra, E.; Wolin, E.; Yao, J.; Pavel, M.; Grande Pulido, E.; Van Cutsem, E.; Seregni, E.; Duarte, H.; Gericke, G.; Bartalotta, A.; Demange, A.; Mutevelic, S.; Krenning, E. |
| Abstract Title: | Overall survival and long-term safety data from the NETTER-1 trial: 177-Lu-DOTATATE vs. high-dose octreotide in patients with progressive midgut NETs |
| Meeting Title: | ESMO 23rd World Congress on Gastrointestinal Cancer |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 3 |
| Meeting Dates: | 2021 Jun 30-Jul 3 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-07-01 |
| Start Page: | S217 |
| End Page: | S218 |
| Language: | English |
| ACCESSION: | WOS:000670004200332 |
| DOI: | 10.1016/j.annonc.2021.05.006 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: O-2 -- Source: Wos |
